Alzheimer's and Dementia

Learn about the types of Alzheimer's research studies and what's involved in participating. Suzanne Newman joins Dr. Cherian Verghese, Principal Researcher at the forefront of Alzheimer's disease at Keystone Clinical Studies LLC in the Philadelphia area. In the phase of informed consent, participants and trial partners are appraised on details about the medicine, that it’s voluntary, outlines potential side effects, not charged to insurance, that participants can withdraw at any time, and that they can also talk to the ethics committee at any time. A trial partner spends time with the participant, a family member, friend, or neighbor — conducting the study needs someone who can tell us about how the participant functions at home with their activities of daily living.

Dr. Paul Winner: “The most advanced evaluations and treatments are inside the research. We are recruiting for an Athira research study and many other studies.”

Deaths from Alzheimer's have increased 141% since 2020, with the global pandemic adversely affecting those with Alzheimer's and their families. Dr. Kay Lehmann, Board Chair of the Alzheimer's Association in the state of Washington, joins Suzanne Newman to talk about all that the Alzheimer's Association does to help those with the disease.

In this segment, Alzheimer's disease and dementia expert Dr. Danielle Goldfarb talks about clinical trials. Dr. Goldfarb is a neurologist and psychiatrist, as well as a physician researcher at Banner Sun Health Research Center in Sun Sun City, Arizona. Clinical trials in an option for some patients, and it’s beneficial to participate. Dr. Goldfarb talks about what happens when you're considering taking part to help determine whether a newly-developed drug is safe, well-tolerated and effective.

Environment plays a major role in daily success of those who are cognitively impaired, especially as symptoms progress. Dr. Shawn Weiss joins Suzanne this hour to talk about ways of adjusting the home environment to improve their quality of life.

This hour with Dementia expert Faith Marshall of Awakenings Hypnosis & Coaching deals with how to communicate with loved ones facing Alzheimer's and dementia....

Certified Dementia Practitioner Amy Schenk joins Suzanne from Cape Coral, Florida, courtesy of Athira Pharma to talk about the difference between normal memory issues as a result of aging and abnormal issues, and indicators to watch for. What happens to our brains as we age normally, as well as what happens when it's not so normal. If you are seeing things that are different in the person you're concerned about, things that make you think "That's not like them," listen to your intuition.

The Walk to End Alzheimer’s is coming to your neighborhood! Here are the dates for Washington State locations: Bremerton, WA 09/07/2019 Coeur d'Alene, ID 09/28/2019 Everett, WA 09/07/2019 Kennewick, WA 10/13/2019 Moses Lake, WA 09/14/2019 Mt....

Courtesy of Athira Pharma, Psychiatrist and Medical Director Bernardo Ng of the Sun Valley Research Center joins Suzanne to talk about Alzheimer's clinical trials, particularly in underserved groups such at the Latino populations in the United States.

Kevin Church, Chief Science Officer of Athira Pharma, provides an overview of clinical trials, how to find clinical trial locations, and what sorts of things the doctors are looking for in a participant.